Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 52023AE0215

    Opinion of the European Economic and Social Committee on ‘Proposal for a Regulation of the European Parliament and of the Council on fees and charges payable to the European Medicines Agency, amending Regulation (EU) 2017/745 of the European Parliament and of the Council and repealing Council Regulation (EC) No 297/95 and Regulation (EU) No 658/2014 of the European Parliament and of the Council’ (COM(2022) 721 final — 2022/0417 (COD))

    EESC 2023/00215

    OJ C 140, 21.4.2023, p. 85–85 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    21.4.2023   

    EN

    Official Journal of the European Union

    C 140/85


    Opinion of the European Economic and Social Committee on ‘Proposal for a Regulation of the European Parliament and of the Council on fees and charges payable to the European Medicines Agency, amending Regulation (EU) 2017/745 of the European Parliament and of the Council and repealing Council Regulation (EC) No 297/95 and Regulation (EU) No 658/2014 of the European Parliament and of the Council’

    (COM(2022) 721 final — 2022/0417 (COD))

    (2023/C 140/15)

    Referral

    Council of the European Union, 22.12.2022

    European Parliament, 15.12.2022

    Legal basis

    Article 114 and Article 168(4)(c) and (b) of the Treaty on the Functioning of the European Union

    Section responsible

    Single Market, Production and Consumption

    Adopted at plenary

    24.1.2023

    Plenary session No

    575

    Outcome of vote

    (for/against/abstentions)

    195/0/1

    Since the Committee unreservedly endorses the proposal and feels that it requires no comment on its part, it has decided to issue an opinion endorsing the proposed text.

    Brussels, 24 January 2023.

    The President of the European Economic and Social Committee

    Christa SCHWENG


    Top